KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Amortization of Goodwill (2019)

Arbutus Biopharma's Amortization of Goodwill history spans 1 years, with the latest figure at $29000.0 for Q4 2019.

  • For Q4 2019, Amortization of Goodwill changed N/A year-over-year to $29000.0; the TTM value through Sep 2020 reached $22.5 million, changed N/A, while the annual FY2019 figure was $22.5 million, N/A changed from the prior year.
  • Amortization of Goodwill for Q4 2019 was $29000.0 at Arbutus Biopharma, down from $22.5 million in the prior quarter.
  • Across five years, Amortization of Goodwill topped out at $22.5 million in Q3 2019 and bottomed at $29000.0 in Q4 2019.